Iron Sucrose As MRI Contrast Agent in Ischemic Stroke Model.
Shiman Wu,Hua Zhang,Jing Wang,Xiaoyan Li,Xinyi Gao,Ziwei Fang,Jianxun Qu,Yue Wu,Yan Ren,Wenting Rui,Junhai Zhang,Zhenwei Yao
DOI: https://doi.org/10.1002/jmri.27109
IF: 4.4
2020-01-01
Journal of Magnetic Resonance Imaging
Abstract:BackgroundDespite the growing concern about the safety of gadolinium‐based contrast agents (GBCAs), they are still the most commonly used. Ferumoxytol, as an off‐label alternative MRI contrast agent, cannot be administered by a rapid bolus for dynamic susceptibility contrast perfusion‐weighted imaging (DSC‐PWI).PurposeTo assess the feasibility of iron sucrose (IS) as a contrast agent for MR angiography (MRA) and DSC‐PWI.Study TypeProspective animal model.Animal ModelThirty‐six normal rats (16 for MRA, 20 for biocompability tests) and 36 occlusion of the middle cerebral artery (MCAO) model rats.Field Strength/Sequence3.0T; head and neck angiography, using a fast spoiled gradient‐recalled‐echo (FSPGR) sequence and DSC‐MRI using echo planar imaging(EPI) sequence.AssessmentMRA was performed on normal rats to examine the signal‐to‐noise ratio (SNR) and contrast‐to‐noise ratio (CNR) of different doses of IS. DSC‐PWI was performed on MCAO rats at 0, 24, 48, and 72 hours postreperfusion to investigate the lesion detectability of IS. Arterial spin labeling (ASL) and DSC‐PWI enhanced by GBCAs were conducted on MCAO rats as controls.Statistical TestsKruskal–Wallis test was used to compare qualitative assessment. One‐way analysis of variance (ANOVA) was used to compare the parametric data. Pearson's r values were evaluated between relative cerebral blood flow(rCBF)‐ASL, rCBF‐DSCIS, and rCBF obtained from DSC‐PWI enhanced by GBCA.ResultsThe mean SNR and CNR of the common carotid artery at doses of 10 mg Fe/kg of IS were comparable with the standard dose of GBCAs (SNR: 68.04 ± 12.55 vs. 67.72 ± 14.66; CNR: 23.78 ± 7.21vs. 21.63 ± 6.83). In MCAO rat models, rCBF and relative cerebral blood volume (rCBV) of ipsilateral striatum declined (0.72 ± 0.14, 0.86 ± 0.11) with prolonged relative mean transit time (rMTT) and relative time‐to‐peak (rTTP) (1.27 ± 0.24, 1.07 ± 0.03) following occlusion. Hyperperfusion was observed in all rats at 48 and 72 hours postreperfusion, in 4/6 rats at 24 hours postreperfusion for IS‐mediated DSC‐PWI.Data ConclusionIS may be an effective contrast agent for both MRA and DSC‐PWI in ischemic stroke models.Level of Evidence1Technical Efficacy Stage1 J. Magn. Reson. Imaging 2020;52:836–849.